个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Blood Loss Volume During Surgery Is a Significant Adverse Prognostic Factor in Patients with Stage I to IIIA Resected NSCLC

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Liang, Wenhua[1] * ; Jiang, Gening[2] ; Wang, Qun[3] ; Liu, Lunxu[4] ; Liu, Deruo[5] ; Wang, Zheng[6] ; Zhu, Zhihua[7] ; He, Jianxing[1] ;
单位： [1]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China [2]Tongji Univ, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China [3]Fudan Univ, Shanghai Zhongshan Hosp, Shanghai 200433, Peoples R China [4]West China Hosp, Chengdu, Peoples R China [5]China & Japan Friendship Hosp, Beijing, Peoples R China [6]Shenzhen PeopleS Hosp, Shenzhen, Peoples R China [7]Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
出处：
ISSN：

关键词： survival NSCLC Surgery Blood Loss Volume

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2014]版：
大类 | 2 区 医学
小类 | 2 区 肿瘤学 2 区 呼吸系统
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2013]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均[2021-2025] 出版当年[2013版] 出版当年五年平均[2009-2013] 出版前一年[2012版] 出版后一年[2014版]

第一作者：
第一作者单位： [1]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714)：
Liang Wenhua,Jiang Gening,Wang Qun,et al.Blood Loss Volume During Surgery Is a Significant Adverse Prognostic Factor in Patients with Stage I to IIIA Resected NSCLC[J].JOURNAL of THORACIC ONCOLOGY.2015,10(9):S556-S556.
APA：
Liang, Wenhua,Jiang, Gening,Wang, Qun,Liu, Lunxu,Liu, Deruo...&He, Jianxing.(2015).Blood Loss Volume During Surgery Is a Significant Adverse Prognostic Factor in Patients with Stage I to IIIA Resected NSCLC.JOURNAL of THORACIC ONCOLOGY,10,(9)
MLA：
Liang, Wenhua,et al."Blood Loss Volume During Surgery Is a Significant Adverse Prognostic Factor in Patients with Stage I to IIIA Resected NSCLC".JOURNAL of THORACIC ONCOLOGY 10..9(2015):S556-S556

相关文献

[1]Intraoperative blood loss, postoperative drainage, and recovery in patients undergoing lumbar spinal surgery [2]Survival and Prognostic Factors of Synchronous Multiple Primary NSCLC and Further Differentiation from Intrapulmonary Metastasis [3]Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels [4]Chinese multi-institutional registry (CMIR) for resected non-small cell lung cancer: survival analysis of 5,853 cases [5]肺鳞状细胞癌450例预后分析 [6]Predictive value of tumor mutation burden (TMB) with targeted next-generation sequencing in immuno-checkpoint inhibitors for non-small cell lung cancer (NSCLC) [7]Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer [8]A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer [9]CircRNA circ_0067934 silencing inhibits the proliferation, migration and invasion of NSCLC cells and correlates with unfavorable prognosis in NSCLC [10]Video-assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non-small cell lung cancer patients

资源点击量：1320 今日访问量：0 总访问量：816 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）